The recently launched ‘GenAI’ tool for U.S. service members and Department of War workers is a ‘critical first step’ in the future of…
-
-
As the year closes, Republicans are looking to the past for another dance with a partisan exercise that tested the party’s unity and…
-
Broadcom stock (NASDAQ: AVGO) climbed Tuesday as investors reassessed the chipmaker’s ability to convert a massive $73 billion AI order book into durable…
-
Obamacare subsidies that have dominated the conversation on Capitol Hill are set to expire after Congress failed to act, but a cohort of…
-
Politics
Trump promises cheaper drugs under TrumpRx, but economists say the long-term costs may be hidden
As President Donald Trump rolls out his TrumpRx proposal to cut prescription drug prices, economists are raising questions about what happens when prices…
-
Turning Point USA’s AmericaFest is very much like a circus, and I mean that in the best possible way. A circus can travel…
-
Editor's PickInvesting
Why FJET stock price crash today may be a buying opportunity for long-term investors
Starfighters Space (FJET) crashed over 50% today as early investors opted to take profit in a stock that – at one point this…
-
Editor's PickInvesting
US midday market brief: stocks climb again, Nvidia and Broadcom lead AI-driven gains
US stocks extended a four-day winning streak as semiconductor giants and AI plays lifted the market toward record territory on Tuesday. The S&P…
-
Editor's PickInvesting
Novo Nordisk stock: does oral Wegovy approval make it better pick than Eli Lilly?
HSBC’s senior research analyst Rajesh Kumar believes Novo Nordisk (NYSE: NVO) “might have an edge” over rival Eli Lilly (NYSE: LLY) heading into…
-
Former U.S. Sen. Ben Sasse of Nebraska announced on Tuesday that he has been diagnosed with metastatic stage-four pancreatic cancer, candidly calling it…